2019
DOI: 10.1007/s10620-019-05683-7
|View full text |Cite
|
Sign up to set email alerts
|

A Risk Assessment of Factors for the Presence of Angiodysplasias During Endoscopy and Factors Contributing to Symptomatic Bleeding and Rebleeds

Abstract: BackgroundFew studies have assessed factors associated with angiodysplasias during endoscopy or factors associated with symptomatic disease.AimsTo evaluate risk factors for the presence of and contribution to symptomatic disease in patients with angiodysplasias.MethodsWe performed a systematic MEDLINE, EMBASE and Cochrane Library search according to the PRISMA guidelines for studies assessing risk factors involved in angiodysplasias detected during endoscopy and factors that lead to anemia or overt bleeding. S… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
16
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(16 citation statements)
references
References 52 publications
0
16
0
Order By: Relevance
“…Many other clinical variables have been associated with an increased risk of rebleeding, such as overt bleeding 55 , low hemoglobin level with higher transfusion requirements 56 57 , CE positive findings 58 59 , ≥ 3 angiectasias 60 61 , lesion size 62 , proximal location in the SB 63 64 , Yano-Yamamoto classification 25 , chronic renal disease 65 66 , cirrhosis 43 , cardiac disease 21 60 , antiplatelet or nonsteroidal anti-inflammatory drug (NSAID) use 47 , among others. Besides the aforementioned Ohmiya score, other scoring systems with clinical applicability have been recently devised for this purpose, integrating and weighting many of the described potential predictive factors to give a magnitude of the risk of rebleeding for each individual patient, allowing physicians to objectively stratify the risk and tailor the follow-up strategy accordingly.…”
Section: Scores For Assessing the Risk Of Rebleeding In Patients With Known Sb Lesionsmentioning
confidence: 99%
“…Many other clinical variables have been associated with an increased risk of rebleeding, such as overt bleeding 55 , low hemoglobin level with higher transfusion requirements 56 57 , CE positive findings 58 59 , ≥ 3 angiectasias 60 61 , lesion size 62 , proximal location in the SB 63 64 , Yano-Yamamoto classification 25 , chronic renal disease 65 66 , cirrhosis 43 , cardiac disease 21 60 , antiplatelet or nonsteroidal anti-inflammatory drug (NSAID) use 47 , among others. Besides the aforementioned Ohmiya score, other scoring systems with clinical applicability have been recently devised for this purpose, integrating and weighting many of the described potential predictive factors to give a magnitude of the risk of rebleeding for each individual patient, allowing physicians to objectively stratify the risk and tailor the follow-up strategy accordingly.…”
Section: Scores For Assessing the Risk Of Rebleeding In Patients With Known Sb Lesionsmentioning
confidence: 99%
“…OGIB is the most frequent indication for VCE, which reveals the presence of AD in 50–60% as the cause of bleeding [17-19]. SBAD manifest clinically as recurrent episodes of anemia associated with occult or visible bleeding [10, 11, 20-22]. In a study involving 56 patients with SBAD, bleeding recurrence occurred in 80% of the cases.…”
Section: Discussionmentioning
confidence: 99%
“…In 2–3% of the cases, they can be the cause of death, particularly in elderly subjects with cardiovascular disease or kidney failure [9]. Bleeding recurrence of SBAD is frequent, so patients require repeated treatments and hospital readmissions, which significantly affect quality of life [10, 11].…”
Section: Introductionmentioning
confidence: 99%
“…Angiectasia is the most commonly found lesion with high bleeding potential among patients undergoing CE for OGIB [ 5 ]. These lesions are associated with chronic blood loss and are most commonly found in the elderly, patients with chronic kidney disease, cardiovascular disease and cirrhosis [ 8 , 9 ]. Other vascular lesions include enteric varices and red spots, which may be found in portal hypertension or diseases with systemic involvement [ 10 - 12 ].…”
Section: Introductionmentioning
confidence: 99%